KEGG   PATHWAY: tfn05200
Entry
tfn05200                    Pathway                                
Name
Pathways in cancer - Trachypithecus francoisi (Francois's langur)
Class
Human Diseases; Cancer: overview
Pathway map
tfn05200  Pathways in cancer
tfn05200

Organism
Trachypithecus francoisi (Francois's langur) [GN:tfn]
Gene
117063884  netrin receptor DCC [KO:K06765]
117083313  caspase-3-like isoform X1 [KO:K02187] [EC:3.4.22.56]
117075139  caspase-3-like isoform X1 [KO:K02187] [EC:3.4.22.56]
117086196  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
117093253  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
117083029  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
117087958  CDH1; cadherin-1 isoform X1 [KO:K05689]
117083938  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
117062099  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
117082678  CTNNA3; catenin alpha-3 [KO:K05691]
117065792  CTNNA1; catenin alpha-1 [KO:K05691]
117097916  AXIN1; axin-1 isoform X1 [KO:K02157]
117067402  AXIN2; axin-2 isoform X1 [KO:K04385]
117064818  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
117076657  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
117083458  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
117065864  TCF7; transcription factor 7 isoform X1 [KO:K02620]
117062119  TCF7L1; transcription factor 7-like 1 [KO:K04490]
117066750  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
117085762  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
117066766  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
117078846  MYC; myc proto-oncogene protein [KO:K04377]
117081518  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
117090185  WNT1; proto-oncogene Wnt-1 [KO:K03209]
117072941  WNT2; protein Wnt-2 [KO:K00182]
117076502  WNT2B; protein Wnt-2b [KO:K00182]
117074535  WNT3A; protein Wnt-3a [KO:K00312]
117067034  uncharacterized protein LOC117067034 [KO:K00312]
117067470  WNT3; proto-oncogene Wnt-3 [KO:K00312]
117093159  WNT4; protein Wnt-4 [KO:K00408]
117090718  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
117083018  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
117094509  WNT6; protein Wnt-6 [KO:K00445]
117096327  WNT7B; protein Wnt-7b [KO:K00572]
117083292  WNT7A; protein Wnt-7a [KO:K00572]
117064599  WNT8A; protein Wnt-8a [KO:K00714]
117068492  WNT8B; protein Wnt-8b [KO:K00714]
117074665  WNT9A; protein Wnt-9a [KO:K01064]
117067211  WNT9B; protein Wnt-9b [KO:K01064]
117090187  WNT10B; protein Wnt-10b [KO:K01357]
117094507  WNT10A; protein Wnt-10a [KO:K01357]
117080124  WNT11; protein Wnt-11 [KO:K01384]
117073269  WNT16; protein Wnt-16 [KO:K01558]
117072635  FZD1; frizzled-1 [KO:K02432]
117094645  FZD7; frizzled-7 [KO:K02432]
117066878  FZD2; frizzled-2 [KO:K02235]
117094272  FZD3; frizzled-3 isoform X1 [KO:K02329]
117081165  FZD4; frizzled-4 isoform X1 [KO:K02354]
117088210  FZD8; frizzled-8 [KO:K02375]
117094596  FZD5; frizzled-5 [KO:K02375]
117078854  FZD6; frizzled-6 isoform X1 [KO:K02376]
117089178  FZD10; frizzled-10 [KO:K02842]
117073094  FZD9; frizzled-9 [KO:K02842]
117079885  LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068]
117090502  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
117083812  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
117093472  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
117067800  DVL2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
117069266  proto-oncogene FRAT1 [KO:K03069]
117069095  FRAT2; LOW QUALITY PROTEIN: GSK-3-binding protein FRAT2 [KO:K03096]
117081636  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
117074039  AGT; angiotensinogen [KO:K09821]
117065283  F2R; proteinase-activated receptor 1 isoform X1 [KO:K03914]
117074734  F2RL3; proteinase-activated receptor 4 [KO:K04236]
117098844  LPAR1; lysophosphatidic acid receptor 1 isoform X1 [KO:K04289]
117080883  LOW QUALITY PROTEIN: lysophosphatidic acid receptor 1-like [KO:K04289]
117076639  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
117092176  LPAR3; lysophosphatidic acid receptor 3 isoform X1 [KO:K04294]
117077340  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
117090633  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
117063259  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
117084057  AGTR1; type-1 angiotensin II receptor [KO:K04166]
117073210  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
117067409  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
117081632  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
117076436  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
117075630  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
117093396  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
117081433  RHOA; transforming protein RhoA [KO:K04513]
117064083  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.39]
117062719  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.39]
117082122  CXCL12; stromal cell-derived factor 1 isoform X1 [KO:K10031]
117095065  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
117072581  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
117081788  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
117075132  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
117076274  PTGER1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
117069645  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
117092092  PTGER3; prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
117065052  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
117068997  neuroendocrine secretory protein 55 [KO:K04632]
117069000  guanine nucleotide-binding protein G(s) subunit alpha isoform X1 [KO:K04632]
117073333  ADCY1; adenylate cyclase type 1 isoform X1 [KO:K08041] [EC:4.6.1.1]
117064735  ADCY2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
117062665  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
117069900  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
117083400  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
117090196  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
117087765  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
117079299  ADCY8; LOW QUALITY PROTEIN: adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
117097725  ADCY9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
117098498  PRKACG; cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
117092158  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
117074523  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
117093437  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
117072288  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
117090616  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
117083766  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
117070643  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
117069650  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 isoform X1 [KO:K07826]
117081093  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
117075268  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 isoform X1 [KO:K04541]
117079628  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5-like [KO:K04542]
117098113  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5-like [KO:K04542]
117062877  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5-like [KO:K04542]
117092172  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
117085990  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5-like [KO:K04542]
117075701  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
117091448  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
117070184  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10-like [KO:K04545]
117098624  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10-like [KO:K04545]
117098837  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
117072627  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
117092073  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
117097878  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
117072272  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
117067187  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
117078318  COL4A6; LOW QUALITY PROTEIN: collagen alpha-6(IV) chain [KO:K06237]
117063510  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
117063511  COL4A1; collagen alpha-1(IV) chain [KO:K06237]
117094430  COL4A3; collagen alpha-3(IV) chain isoform X1 [KO:K06237]
117094436  COL4A4; collagen alpha-4(IV) chain isoform X1 [KO:K06237]
117077535  COL4A5; LOW QUALITY PROTEIN: collagen alpha-5(IV) chain [KO:K06237]
117097545  LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637]
117064126  LAMA1; laminin subunit alpha-1 isoform X1 [KO:K05637]
117069038  LAMA5; laminin subunit alpha-5 isoform X1 [KO:K06240]
117064051  laminin subunit alpha-3 [KO:K06240]
117096947  LAMA4; laminin subunit alpha-4 isoform X1 [KO:K06241]
117073371  LAMB1; laminin subunit beta-1 isoform X1 [KO:K05636]
117081297  LAMB2; laminin subunit beta-2 [KO:K06243]
117075364  LAMB3; laminin subunit beta-3 [KO:K06244]
117072853  LAMB4; laminin subunit beta-4 isoform X1 [KO:K06245]
117076850  LAMC1; laminin subunit gamma-1 [KO:K05635]
117074462  LAMC2; laminin subunit gamma-2 [KO:K06246]
117073359  LAMC3; laminin subunit gamma-3 [KO:K06247]
117094564  FN1; fibronectin isoform X1 [KO:K05717]
117065104  ITGA2; integrin alpha-2 isoform X1 [KO:K06481]
117066881  ITGA2B; integrin alpha-IIb isoform X1 [KO:K06476]
117067204  ITGA3; integrin alpha-3 isoform X1 [KO:K06482]
117094852  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
117094753  ITGAV; integrin alpha-V isoform X1 [KO:K06487]
117082160  ITGB1; integrin beta-1 isoform X1 [KO:K05719]
117079459  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
117083761  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
117084122  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
117093348  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
117065206  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
117092662  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
117075022  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
117086074  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
117093523  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
117071286  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
117091956  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
117076331  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
117068535  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
117095630  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
117078341  IKBKG; LOW QUALITY PROTEIN: NF-kappa-B essential modulator [KO:K07210]
117069810  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
117085710  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
117067669  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
117081405  RELA; transcription factor p65 [KO:K04735]
117074573  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
117067605  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
117099723  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
117080066  BIRC3; baculoviral IAP repeat-containing protein 3 isoform X1 [KO:K16060]
117080067  BIRC2; baculoviral IAP repeat-containing protein 2 isoform X1 [KO:K16060]
117077500  XIAP; LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
117069100  BIRC7; baculoviral IAP repeat-containing protein 7 isoform X1 [KO:K16061]
117068616  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
117098744  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
117099135  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
117071333  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
117066115  TNF receptor-associated factor 4-like [KO:K09848]
117066440  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
117074021  TRAF5; TNF receptor-associated factor 5 [KO:K09849]
117080232  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
117093322  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
117080241  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
117067326  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
117080612  BAD; bcl2-associated agonist of cell death [KO:K02158]
117097036  FOXO1; forkhead box protein O1 isoform X1 [KO:K07201]
117089769  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
117067758  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
117090495  CDKN1B; cyclin-dependent kinase inhibitor 1B isoform X1 [KO:K06624]
117087134  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
117095919  BCR; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
117073329  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
117096632  CRKL; crk-like protein [KO:K04438]
117067958  CRK; adapter molecule crk isoform X1 [KO:K04438]
117081759  CBL; E3 ubiquitin-protein ligase CBL isoform X1 [KO:K04707] [EC:2.3.2.27]
117066964  STAT5A; LOW QUALITY PROTEIN: signal transducer and activator of transcription 5A [KO:K11223]
117066965  signal transducer and activator of transcription 5B isoform X1 [KO:K11224]
117087147  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
117077491  PIM2; LOW QUALITY PROTEIN: serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
117084346  KNG1; kininogen-1 [KO:K03898]
117086734  EDN1; endothelin-1 [KO:K16366]
117071446  B2 bradykinin receptor isoform X1 [KO:K03916]
117085996  EDNRA; endothelin-1 receptor isoform X1 [KO:K04197]
117063659  EDNRB; endothelin receptor type B [KO:K04198]
117098435  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha isoform X1 [KO:K04634]
117074394  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
117070870  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
117080608  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
117068469  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
117068471  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
117067396  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
117087485  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
117091710  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
117084792  IL2; interleukin-2 [KO:K05429]
117064606  IL3; interleukin-3 [KO:K04736]
117065885  IL4; interleukin-4 [KO:K05430]
117065890  IL5; interleukin-5 [KO:K05428]
117072793  IL6; interleukin-6 isoform X1 [KO:K05405]
117079493  IL7; interleukin-7 isoform X1 [KO:K05431]
117079203  IL12A; interleukin-12 subunit alpha [KO:K05406]
117065537  IL12B; interleukin-12 subunit beta [KO:K05425]
117065886  IL13; interleukin-13 [KO:K05435]
117085957  IL15; interleukin-15 isoform X1 [KO:K05433]
117089933  IL23A; interleukin-23 subunit alpha [KO:K05426]
117073046  EPO; erythropoietin isoform X1 [KO:K05437]
117098645  interferon alpha-4-like [KO:K05414]
117098649  interferon alpha-6 [KO:K05414]
117098650  interferon alpha-1/13 [KO:K05414]
117098651  interferon alpha-1/13-like [KO:K05414]
117098652  IFNA2; interferon alpha-2 [KO:K05414]
117099353  interferon alpha-4 [KO:K05414]
117099354  interferon alpha-14 [KO:K05414]
117099355  IFNA8; interferon alpha-8 [KO:K05414]
117099357  interferon alpha-1/13 [KO:K05414]
117089783  IFNG; interferon gamma [KO:K04687]
117082099  IL2RA; interleukin-2 receptor subunit alpha isoform X1 [KO:K05068]
117070006  IL2RB; interleukin-2 receptor subunit beta isoform X1 [KO:K05069]
117077624  IL2RG; cytokine receptor common subunit gamma isoform X1 [KO:K05070]
117076154  IL3RA; interleukin-3 receptor subunit alpha isoform X1 [KO:K04737]
117087558  IL4R; interleukin-4 receptor subunit alpha isoform X1 [KO:K05071]
117095970  CSF2RB; cytokine receptor common subunit beta isoform X1 [KO:K04738]
117083166  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
117075908  IL6R; interleukin-6 receptor subunit alpha isoform X1 [KO:K05055]
117065139  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
117065018  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
117074814  IL12RB1; interleukin-12 receptor subunit beta-1 isoform X1 [KO:K05063]
117092067  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
117078386  IL13RA1; interleukin-13 receptor subunit alpha-1 isoform X1 [KO:K05076]
117082582  IL15RA; interleukin-15 receptor subunit alpha isoform X1 [KO:K05074]
117092066  IL23R; interleukin-23 receptor [KO:K05065]
117074482  EPOR; erythropoietin receptor isoform X1 [KO:K05079]
117095712  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
117095709  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
117097473  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
117095714  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
117062414  EML4; echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
117062859  ALK; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
117070893  RASGRP1; RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
117081424  RASGRP2; RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
117062489  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
117092476  RASGRP4; RAS guanyl-releasing protein 4 isoform X1 [KO:K12363]
117092033  JAK1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
117098543  JAK2; tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
117076455  JAK3; tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
117066962  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
117094713  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
117089929  STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
117094711  STAT4; signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
117089901  STAT6; signal transducer and activator of transcription 6 isoform X1 [KO:K11225]
117087278  VEGFA; vascular endothelial growth factor A isoform X1 [KO:K05448]
117069324  PGF; placenta growth factor isoform X1 [KO:K16859]
117086157  VEGFC; vascular endothelial growth factor C [KO:K05449]
117077572  VEGFD; vascular endothelial growth factor D [KO:K05449]
117061979  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
117085785  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
117073506  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
117067088  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
117072614  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
117096471  PDGFB; platelet-derived growth factor subunit B [KO:K17386]
117085606  PDGFRA; platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
117065596  PDGFRB; platelet-derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
117089531  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
117081142  IGF2; insulin-like growth factor II isoform X1 [KO:K13769]
117070145  IGF1R; insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
117089655  KITLG; kit ligand isoform X1 [KO:K05461]
117085603  KIT; mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
117091573  FLT3LG; fms-related tyrosine kinase 3 ligand isoform X1 [KO:K05454]
117097942  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
117072632  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
117073436  MET; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
117065686  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
117085877  FGF2; fibroblast growth factor 2 [KO:K18497]
117079898  FGF3; fibroblast growth factor 3 [KO:K04358]
117070685  FGF7; fibroblast growth factor 7 [KO:K04358]
117080722  FGF4; fibroblast growth factor 4 [KO:K04358]
117090673  FGF6; fibroblast growth factor 6 [KO:K04358]
117065085  FGF10; fibroblast growth factor 10 [KO:K04358]
117074128  FGF22; fibroblast growth factor 22 isoform X1 [KO:K04358]
117092120  FGF20; fibroblast growth factor 20 [KO:K04358]
117065449  FGF18; fibroblast growth factor 18 [KO:K04358]
117074964  FGF9; fibroblast growth factor 9 [KO:K04358]
117092974  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
117085405  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
117067885  FGF8; fibroblast growth factor 8 isoform X1 [KO:K04358]
117077528  FGF16; fibroblast growth factor 16 [KO:K04358]
117080426  FGF19; fibroblast growth factor 19 [KO:K22603]
117093783  FGF21; fibroblast growth factor 21 [KO:K22429]
117090674  FGF23; fibroblast growth factor 23 [KO:K22428]
117094867  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
117065679  FGFR2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
117085041  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
117065345  FGFR4; LOW QUALITY PROTEIN: fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
117066678  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
117069667  SOS2; LOW QUALITY PROTEIN: son of sevenless homolog 2 [KO:K03099]
117062427  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
117081688  HRAS; GTPase HRas isoform X1 [KO:K02833]
117074634  NRAS; GTPase NRas [KO:K07828]
117078298  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
117072297  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
117083269  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
117084479  LOW QUALITY PROTEIN: RAF proto-oncogene serine/threonine-protein kinase-like [KO:K04366] [EC:2.7.11.1]
117070473  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
117076490  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
117087606  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
117096627  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
117091985  JUN; transcription factor AP-1 [KO:K04448]
117069314  FOS; proto-oncogene c-Fos [KO:K04379]
117080501  ETS1; protein C-ets-1 isoform X1 [KO:K02678]
117081260  MMP1; interstitial collagenase [KO:K01388] [EC:3.4.24.7]
117087797  MMP2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
117068860  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
117085498  CXCL8; interleukin-8 [KO:K10030]
117089862  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
117071546  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
117082351  RET; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
117082740  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
117082063  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
117076785  NTRK1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
117089706  tropomyosin alpha-3 chain-like [KO:K09290]
117090245  tropomyosin alpha-3 chain isoform X1 [KO:K09290]
117093642  tropomyosin alpha-3 chain-like isoform X1 [KO:K09290]
117075847  TPR; nucleoprotein TPR [KO:K09291]
117083596  TFG; protein TFG isoform X1 [KO:K09292]
117082000  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
117075886  RASSF5; ras association domain-containing protein 5 isoform X1 [KO:K08015]
117068819  STK4; serine/threonine-protein kinase 4 [KO:K04411]
117070531  DAPK2; death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
117098396  DAPK1; death-associated protein kinase 1 isoform X1 [KO:K08803] [EC:2.7.11.1]
117075779  DAPK3; death-associated protein kinase 3 isoform X1 [KO:K08803] [EC:2.7.11.1]
117068778  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
117088112  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
117078321  ELK1; ETS domain-containing protein Elk-1 isoform X1 [KO:K04375]
117080423  ETS domain-containing protein Elk-1-like [KO:K04375]
117069878  calmodulin-1-like [KO:K02183]
117079553  calmodulin-1-like [KO:K02183]
117070455  CALML4; LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
117070827  calmodulin-1 [KO:K02183]
117062348  CALM2; calmodulin-2 [KO:K02183]
117071553  CALM1; calmodulin-1 [KO:K02183]
117091446  CALM3; calmodulin-3 [KO:K02183]
117082197  CALML3; calmodulin-like protein 3 [KO:K02183]
117082198  CALML5; calmodulin-like protein 5 [KO:K02183]
117093967  CALML6; calmodulin-like protein 6 isoform X1 [KO:K02183]
117095064  calmodulin-1-like [KO:K02183]
117081990  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
117073301  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
117065600  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
117085812  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
117073836  RALGDS; LOW QUALITY PROTEIN: ral guanine nucleotide dissociation stimulator [KO:K08732]
117087293  ral-GDS-related protein-like isoform X1 [KO:K08732]
117073171  RALA; ras-related protein Ral-A [KO:K07834]
117095133  RALB; ras-related protein Ral-B [KO:K07835]
117089561  ralA-binding protein 1-like [KO:K08773]
117064147  RALBP1; ralA-binding protein 1 [KO:K08773]
117063724  cell division control protein 42 homolog [KO:K04393]
117093160  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
117073672  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
117085754  ras-related C3 botulinum toxin substrate 1-like [KO:K04392]
117070036  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
117066362  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
117083734  PLD1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
117067870  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
117082864  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
117065429  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
117085362  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
117062176  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
117083265  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
117099190  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
117087032  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
117075381  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
117084254  RARB; retinoic acid receptor beta isoform X1 [KO:K08528]
117097264  ESR1; estrogen receptor isoform X1 [KO:K08550]
117069483  ESR2; estrogen receptor beta isoform X1 [KO:K08551]
117062663  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
117068880  NCOA3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
117090035  SP1; transcription factor Sp1 [KO:K04684]
117087099  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
117066989  JUP; junction plakoglobin [KO:K10056]
117081507  ZBTB16; zinc finger and BTB domain-containing protein 16 isoform X1 [KO:K10055]
117067065  RARA; retinoic acid receptor alpha isoform X1 [KO:K08527]
117097337  CCNA1; cyclin-A1 isoform X1 [KO:K06627]
117085863  CCNA2; cyclin-A2 [KO:K06627]
117070383  PML; protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
117095741  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
117078903  RUNX1T1; protein CBFA2T1 isoform X1 [KO:K10053]
117080415  SPI1; transcription factor PU.1 isoform X1 [KO:K09438]
117092292  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
117076099  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha isoform X1 [KO:K05066]
117087217  granulocyte colony-stimulating factor receptor-like [KO:K05061]
117092868  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
117065594  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
117098660  CDKN2A; cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
117068658  E2F1; LOW QUALITY PROTEIN: transcription factor E2F1 [KO:K17454]
117093139  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
117086783  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
117069468  MAX; protein max isoform X1 [KO:K04453]
117093243  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
117098659  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
117073473  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
117090678  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
117087209  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
117098368  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
117071155  cyclin-dependent kinases regulatory subunit 1-like [KO:K02219]
117080776  cyclin-dependent kinases regulatory subunit 1-like [KO:K02219]
117075165  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
117076351  cyclin-dependent kinases regulatory subunit 2-like [KO:K02219]
117069498  S-phase kinase-associated protein 1-like [KO:K03094]
117090435  S-phase kinase-associated protein 1-like [KO:K03094]
117065865  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
117073499  CUL1; cullin-1 [KO:K03347]
117096433  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
117065023  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
117089961  CDK2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
117079029  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
117092263  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
117063258  RB1; retinoblastoma-associated protein [KO:K06618]
117098362  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
117092072  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
117075703  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
117091541  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
117087056  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
117096195  bcl-2 homologous antagonist/killer-like [KO:K14021]
117080146  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
117065273  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
117064701  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]
117083122  MITF; microphthalmia-associated transcription factor isoform X1 [KO:K09455]
117075968  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
117074794  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
117069299  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
117098928  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
117084287  TGFBR2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
117063928  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
117070466  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
117063892  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
117083696  MECOM; histone-lysine N-methyltransferase MECOM isoform X1 [KO:K04462] [EC:2.1.1.367]
117065159  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
117085026  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
117096953  HDAC2; histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
117092947  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
117094391  histone deacetylase 1-like [KO:K06067] [EC:3.5.1.98]
117083867  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
117062345  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
117064968  MSH3; DNA mismatch repair protein Msh3 isoform X1 [KO:K08736]
117062337  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
117097609  BRCA2; LOW QUALITY PROTEIN: breast cancer type 2 susceptibility protein [KO:K08775]
117070859  RAD51; DNA repair protein RAD51 homolog 1 isoform X1 [KO:K04482]
117074605  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
117086221  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
117079989  FADD; FAS-associated death domain protein [KO:K02373]
117094661  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
117096070  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
117099591  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
117091464  BBC3; bcl-2-binding component 3 isoform X1 [KO:K10132]
117062210  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
117078921  cytochrome c-like [KO:K08738]
117078953  cytochrome c-like [KO:K08738]
117096842  cytochrome c-like [KO:K08738]
117079868  cytochrome c-like [KO:K08738]
117097957  cytochrome c-like [KO:K08738]
117098492  cytochrome c-like [KO:K08738]
117080718  cytochrome c-like [KO:K08738]
117072525  cytochrome c [KO:K08738]
117072825  cytochrome c-like [KO:K08738]
117081557  cytochrome c-like [KO:K08738]
117083033  cytochrome c-like [KO:K08738]
117093380  cytochrome c-like [KO:K08738]
117089565  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
117066706  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
117076190  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
117094810  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
117095936  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
117087977  NQO1; NAD(P)H dehydrogenase [quinone] 1 isoform X1 [KO:K00355] [EC:1.6.5.2]
117078076  glutathione S-transferase omega-1-like [KO:K00799] [EC:2.5.1.18]
117087357  glutathione S-transferase A1 [KO:K00799] [EC:2.5.1.18]
117087358  glutathione S-transferase A3 [KO:K00799] [EC:2.5.1.18]
117087359  glutathione S-transferase A4 isoform X1 [KO:K00799] [EC:2.5.1.18]
117087887  microsomal glutathione S-transferase 1-like [KO:K00799] [EC:2.5.1.18]
117096564  glutathione S-transferase theta-4-like [KO:K00799] [EC:2.5.1.18]
117070174  glutathione S-transferase Mu 5-like [KO:K00799] [EC:2.5.1.18]
117088539  LOW QUALITY PROTEIN: glutathione S-transferase A4-like [KO:K00799] [EC:2.5.1.18]
117089797  glutathione S-transferase Mu 2-like [KO:K00799] [EC:2.5.1.18]
117062130  glutathione S-transferase Mu 3-like [KO:K00799] [EC:2.5.1.18]
117090442  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
117074295  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
117067243  GSTO2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
117067248  GSTO1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
117075949  GSTM3; glutathione S-transferase Mu 3 isoform X1 [KO:K00799] [EC:2.5.1.18]
117075950  glutathione S-transferase Mu 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
117075952  GSTM4; glutathione S-transferase Mu 4 isoform X1 [KO:K00799] [EC:2.5.1.18]
117075953  glutathione S-transferase Mu 5 isoform X1 [KO:K00799] [EC:2.5.1.18]
117075998  GSTT2B; glutathione S-transferase theta-2B [KO:K00799] [EC:2.5.1.18]
117076051  glutathione S-transferase theta-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
117076337  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
117085934  MGST2; microsomal glutathione S-transferase 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
117094970  glutathione S-transferase Mu 3-like [KO:K00799] [EC:2.5.1.18]
117081010  GSTP1; glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
117078214  TXNRD3; LOW QUALITY PROTEIN: thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
117096028  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
117089505  TXNRD1; thioredoxin reductase 1, cytoplasmic isoform X1 [KO:K22182] [EC:1.8.1.9]
117081616  LOW QUALITY PROTEIN: thioredoxin reductase 1, cytoplasmic-like [KO:K22182] [EC:1.8.1.9]
117074121  VHLL; LOW QUALITY PROTEIN: von Hippel-Lindau-like protein [KO:K03871]
117083240  VHL; von Hippel-Lindau disease tumor suppressor isoform X1 [KO:K03871]
117078905  ELOC; elongin-C isoform X1 [KO:K03872]
117061988  elongin-C-like [KO:K03872]
117073108  elongin-C-like [KO:K03872]
117082523  LOW QUALITY PROTEIN: elongin-C-like [KO:K03872]
117092213  elongin-C-like [KO:K03872]
117079944  elongin-B-like [KO:K03873]
117097776  ELOB; elongin-B isoform X1 [KO:K03873]
117082274  CUL2; cullin-2 [KO:K03870]
117082978  cullin-2-like isoform X1 [KO:K03870]
117069837  EGLN3; egl nine homolog 3 isoform X1 [KO:K09592] [EC:1.14.11.29]
117091935  EGLN2; egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
117075653  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
117070004  fumarate hydratase, mitochondrial-like [KO:K01679] [EC:4.2.1.2]
117062307  LOW QUALITY PROTEIN: fumarate hydratase, mitochondrial-like [KO:K01679] [EC:4.2.1.2]
117074590  FH; fumarate hydratase, mitochondrial isoform X1 [KO:K01679] [EC:4.2.1.2]
117069504  HIF1A; hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
117062363  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
117075081  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
117070296  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
117096425  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
117097726  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
117092745  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
117068459  JAG1; protein jagged-1 [KO:K06052]
117071272  JAG2; protein jagged-2 isoform X1 [KO:K21635]
117096844  DLL1; delta-like protein 1 [KO:K06051]
117070820  DLL4; delta-like protein 4 [KO:K06051]
117092520  DLL3; delta-like protein 3 isoform X1 [KO:K06051]
117099151  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
117075644  NOTCH2; neurogenic locus notch homolog protein 2 isoform X1 [KO:K20994]
117074777  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
117086998  NOTCH4; LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 4 [KO:K20996]
117084404  HES1; transcription factor HES-1 [KO:K06054]
117093965  HES5; transcription factor HES-5 [KO:K06055]
117079008  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091]
117097027  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091]
117092816  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091]
117064804  FLT4; vascular endothelial growth factor receptor 3 isoform X1 [KO:K05097] [EC:2.7.10.1]
117073036  SHH; sonic hedgehog protein isoform X1 [KO:K11988]
117098271  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
117072063  SMO; smoothened homolog isoform X1 [KO:K06226]
117070231  KIF7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
117067625  SUFU; suppressor of fused homolog isoform X1 [KO:K06229]
117089878  GLI1; zinc finger protein GLI1 [KO:K16797]
117095137  GLI2; zinc finger protein GLI2 [KO:K16798]
117073239  GLI3; transcriptional activator GLI3 [KO:K06230]
117068478  BMP2; bone morphogenetic protein 2 [KO:K21283]
117069628  BMP4; bone morphogenetic protein 4 isoform X1 [KO:K04662]
117085973  HHIP; hedgehog-interacting protein isoform X1 [KO:K06231]
117092691  PTCH2; protein patched homolog 2 isoform X1 [KO:K11101]
117077749  AR; LOW QUALITY PROTEIN: androgen receptor [KO:K08557]
117083296  androgen receptor [KO:K08557]
117087288  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
117069698  LOW QUALITY PROTEIN: heat shock protein HSP 90-alpha-like [KO:K04079]
117071348  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
117082707  heat shock protein HSP 90-beta-like [KO:K04079]
117074457  heat shock protein HSP 90-beta-like [KO:K04079]
117089519  HSP90B1; endoplasmin [KO:K09487]
117091652  prostate-specific antigen isoform X1 [KO:K01351] [EC:3.4.21.77]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
tfn03320  PPAR signaling pathway
tfn04010  MAPK signaling pathway
tfn04020  Calcium signaling pathway
tfn04024  cAMP signaling pathway
tfn04060  Cytokine-cytokine receptor interaction
tfn04066  HIF-1 signaling pathway
tfn04110  Cell cycle
tfn04115  p53 signaling pathway
tfn04150  mTOR signaling pathway
tfn04151  PI3K-Akt signaling pathway
tfn04210  Apoptosis
tfn04310  Wnt signaling pathway
tfn04330  Notch signaling pathway
tfn04340  Hedgehog signaling pathway
tfn04350  TGF-beta signaling pathway
tfn04370  VEGF signaling pathway
tfn04510  Focal adhesion
tfn04512  ECM-receptor interaction
tfn04520  Adherens junction
tfn04630  JAK-STAT signaling pathway
tfn04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system